vTv Therapeutics (NASDAQ:VTVT) Research Coverage Started at HC Wainwright
HC Wainwright assumed coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a report issued on Wednesday, Marketbeat reports. The brokerage issued a buy rating and a $36.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for vTv Therapeutics’ Q1 2025 earnings at ($0.73) EPS, Q2 2025 earnings at […]
HC Wainwright assumed coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a report issued on Wednesday, Marketbeat reports. The brokerage issued a buy rating and a $36.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for vTv Therapeutics’ Q1 2025 earnings at ($0.73) EPS, Q2 2025 earnings at […]